慢性肾脏病血管钙化研究进展

摘要
图/表
参考文献(37)
相关文章 (15)

全文: PDF (0 KB) HTML (40 KB)
输出: BibTeX | EndNote (RIS)

摘要心血管疾病（CVD）是导致慢性肾脏病（CKD）患者死亡的最常见原因。血管钙化可以造成患者的CVD患病率升高，CKD患者的血管钙化是一种由矿物质代谢异常、激素水平改变、细胞信号通路异常激活、表观遗传学调控等引起的复杂的生理过程。本文综述了CKD患者血管钙化的特点、机制、影响因素等方面的研究进展。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨星梦
	马晓迎
	生玉平
	徐海平
	张浩然
	王娜
	孙福云

关键词 ：慢性肾脏病, 血管钙化, 发病机制, 心血管疾病

Abstract：Cardiovascular disease (CVD)is the most commom factor for death in patients with chronic kidney disease(CKD).Vascular calcification could promote the morbidty of CVD.Vascular calcification of patients with CKD is a complex biological process which is mediated by the dysregulated form of matrix mineral metabolism,change of hormones,epigenetic regulation and the activation of cellular signaling pathways.This paper reviewed the characteristics,physiological mechanism,influence factors of vascular calcificationin in patients with CKD.

Key words： Chronic kidney disease Vascular calcification Pathogenesis Cardiovascular disease

基金资助:河北省沧州市重点研发计划指导项目（204106081）。

引用本文:

杨星梦；马晓迎；生玉平；徐海平；张浩然；王娜；孙福云. 慢性肾脏病血管钙化研究进展[J]. 中国当代医药, 2021, 28(31): 33-36.
YANG Xing-meng；MA Xiao-ying；SHENG Yu-ping；XU Hai-ping；ZHANG Hao-ran；WANG Na；SUN Fu-yun. Updates on vascular calcification in chronic kidney disease. 中国当代医药, 2021, 28(31): 33-36.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2021/V28/I31/33

[1]	Vervloet M，Cozzolino M.Vascular calcification in chronic kidney disease：different bricks in the wall?[J].Kidney Int，2017，91（4）：808-817.
[2]	Hénaut L，Chillon JM，Kamel S，et al.Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease[J].Semin Nephrol，2018，38（3）：233-250.
[3]	Yamada S，Giachelli CM.Vascular calcifification in CKDMBD：roles for phosphate，FGF23，and Klotho[J].Bone，2017，100：87-93.
[4]	Schlieper G，Schurgers L，Brandenburg V，et al.Vascular calcification in chronic kidney disease：An update[J].Nephrol Dial Transplant，2016，31（1）：31-39.
[5]	Lang F，Leibrock C，Pelzl L，et al.Therapeutic interference with vascular calcifification-lessons from klotho-hypomorphic mice and beyond[J].Fro-nt Endocrinol（Lausanne），2018，9（4）：207.
[6]	刘保岩，韩金祥，鲁艳芹.基质小泡与血管钙化的关系[J].中华老年医学杂志，2016，35（2）：221-225．
[7]	Dai XY，Zhao MM，Cai Y，et al.Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release[J].Kidney Int，2013，83（6）：1042-1051.
[8]	Voelkl J，Tuffaha R，Luong TTD，et al.Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB[J].J Am Soc Nephrol，2018，29（6）：1636-1648.
[9]	Coscas R，Bensussan M，Jacob MP，et al.Free DNA precipitates calcium phosphate apatite crystals in the arterial wall in vivo[J].Atherosclerosis，2017，25（9）：60-67.
[10]	Villa-Bellosta R，Hamczyk MR，Andrés V.Novel phosphateactivated macrophages prevent ectopic calcifification by increasing extracellular ATP and pyrophosphate[J].PLoS One，2017，12（3）：e0174998.
[11]	Yang H，Curinga G，Giachelli CM.Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro[J].Kidney Int，2004，66（6）：2293-2299.
[12]	Masumoto A，Sonou T，Ohya M，et al.Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1，but not the Calcium-Sensing Receptor[J].J Atheroscler Thromb，2017，24（7）：716-724.
[13]	Rivara MB，Ravel V，Kalantar-Zadeh K，et al.Uncorrected and Albumin-Corrected Calcium，Phosphorus，and Mortali-ty in Patients Undergoing Maintenance Dialysis[J].J Am Soc Nephrol，2015，26（7）：1671-1681.
[14]	Kazmi AS，Wall BM.Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism[J].Am J Med Sci，2007，333（4）：226-229.
[15]	Portillo MR，Rodríguez-Ortiz ME.Secondary Hyperparthyroidism：Pathogenesis，Diagnosis，Preventive and Therapeutic Strategies[J].Rev Endocr Metab Disord，2017，18（1）：79-95.
[16]	Iguchi A，Watanabe Y，Iino N，et al.Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in hemodialysis patients[J].Nephrology，2014，19（11）：667-671.
[17]	Kazmi AS，Wall BM.Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism[J].Am J Med Sci，2007，333（4）：226-229.
[18]	Di Lullo L，Gorini A，Bellasi A，et al.Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease[J].Clin Kidney J，2015，8（6）：732-736.
[19]	Chang JR，Guo J，Wang Y，et al.Intermedin1-53 attenuates vascular calcifification in rats with chronic kidney disease by upregulation of α-Klotho[J].Kidney Int，2016，89（6）：586-600.
[20]	Ndip A，Williams A，Jude EB，et al.The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charco neuroarthropathy[J].Diabetes，2011，60（8）：2187-2196.
[21]	Briet M，Burns KD.Chronic kidney disease and vascular remodelling：molecular mechanisms and clinical implications[J].Clin Sci，2012，123（7）：399-416.
[22]	Goldfarb S，Martin K.Disorders of divalent ions，renal bone disease and nephrolithiasis[J].Nephrol Self Assess Program，2018，17（3）：205-209.
[23]	Kukida M，Mogi M，Kan-No H，et al.AT2 receptor stimulation inhibits phosphate-induced vascular calcifification[J].Kidney Int，2019，95（1）：138-148.
[24]	Chung S，Kim M，Koh ES，et al.Serum 1，25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases[J].Int J Med Sci，2017，14（11）：1080-1087.
[25]	Gmciolli FG，Neves KR，Barreto F，et al.The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease[J].Kidney Int，2017，91（6）：1436-1446．
[26]	Sprague SM，Bellorin-Font E，Jorgetti V，et al.Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis[J].Am J Kidney Dis，2016，67（4）：559-566.
[27]	Xie SA，Zhang T，Wang J，et al.Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo：role of DNA methyltransferase 1[J].Biomaterials，2018，155：203-216.
[28]	Bradley EW，Carpio LR，Olson EN，et al.Histone deacetylase 7（Hdac7）suppresses chondrocyte proliferation and βcatenin activity during endochondral ossification[J].J Biol Chem，2015，290（1）：118-126.
[29]	Zhang H，Chen J，Shen Z，et al.Indoxyl sulfate accelerates vascular smooth muscle cell calcifification via microRNA-29b dependent regula-tion of Wnt/beta-catenin signaling[J].Toxicol Lett，2018，284（1）：29-36.
[30]	Xu TH，Qiu XB，Sheng ZT，et al.Restoration of microRNA-30b expression alleviates vascular calcifification through the mTOR signaling pathway and autophagy[J].J Cell Physiol，2019，234（8）：14306-14318.
[31]	Lee CT，Lee YT，Tain YL，et al.Circulating microRNAs and vascular calcifification in hemodialysis patients[J].J Int Med Res，2019，47（7）：2929-2939.
[32]	Wang Y，Luo W，Han J，et al.MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy[J].Nat Commun，2020，11（1）：2148.
[33]	Viaene L，Behets GJ，Heye S，et al.Inflammation and the bone-vascular axis in end-stage renal disease[J].Osteoporos Int，2016，27（2）：489-497.
[34]	Buendía P，Montes de Oca A，Madueno JA，et al.Endothelial microparticles mediate inflammation-induced vascular calcification[J].FASEB J，2015，29（1）：173-181.
[35]	Liu Y，Wang WM，Zhang XL，et al.AGE/RAGE promotes the calcifification of human aortic smooth muscle cells via the Wnt/β-catenin axis[J].Am J Transl Res，2016，8（11）：4644-4656.
[36]	Hénaut L，Sanchez-Nino MD，Aldamiz-Echevarría Castillo G，et al.Targeting local vascular and systemic consequences of inflflammation on vascular and cardiac valve calcifification[J].Expert Opin Ther Targets，2016，20（1）：89-105.
[37]	Chao CT，Yeh HY，Tsai YT，et al.Natural and non-natural antioxidative compounds：potential candidates for treatment of vasc-ular calcififi-cation[J].Cell Death Discov，2019，13（5）：145.